← Leaderboards
Howard J Heller
University Of Texas Sw Med Ctr/Dallas
$2,980,605
Attributed
$2,980,605
Total exposure
10
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $70.1K · FY2005–06$100K$75K$50K$25K$0
'05
'06
Funding mix
By agency
NIH$2,980,605 · 10
By mechanism
M01$2,136,416 · 8
K23$615,642 · 1
P01$228,547 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Sw Med Ctr/Dallas
Same institution · by research overlap
- Orson W Moe$15,748,560
- Nitin J Karandikar$13,410,907
- Chou-Long Huang$19,641,363
- Charles Y.c Pak$11,557,463
- Khashayar Sakhaee$14,492,169
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchHypercalciuriaNutrition Related TagBone DensityDietary CalciumNephrolithiasisNutrient Intake ActivityParathyroid HormonesUrinalysisPhosphatesHuman Therapy EvaluationCalciumCitratesCalcium MetabolismPathologic Bone ResorptionBone MetabolismAlkaline PhosphataseMalabsorptionBlood ChemistryCareerMorphometryDiet TherapyDietary Sodium
Grant awards (24)
ROLE OF BONE IN ABSORPTIVE HYPERCALCIURIA$16,826
M01 · FY2006 · RR · contact PI
DOES MELATONIN REDUCE URINARY CALCIUM IN HYPERCALCIURIC STONE-FORMERS?$4,723
M01 · FY2006 · RR · contact PI
FIBROBLAST GROWTH FACTOR 23: CIRCADIAN RHYTHM & RESPONSE TO ORAL LOAD OF CA OR P$4,133
M01 · FY2006 · RR · contact PI
ROLE OF BONE IN ABSORPTIVE HYPERCALCIURIA$41,758
M01 · FY2005 · RR
DOES MELATONIN REDUCE URINARY CALCIUM IN HYPERCALCIURIC STONE-FORMERS?$28,311
M01 · FY2005 · RR
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT AW$123,390
K23 · FY2004 · RR
Role of Bone in Absorptive Hypercalciuria$42,524
M01 · FY2004 · RR
Does melatonin reduce urinary calcium in hypercalciuric stone-formers?$221
M01 · FY2004 · RR
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT AW$123,390
K23 · FY2003 · RR
STONE FORMING RISK OF CALCIUM CONSUMPTION$321,374
M01 · FY2002 · RR
'UPREGULATED STATES'OF THE VITAMIN D RECEPTOR$321,374
M01 · FY2002 · RR
COMPARATIVE EFFECTS OF CITRACAL, OSCAL, &TUMS ON INTESTINAL CALCIUM$321,374
M01 · FY2002 · RR
HYPERCALCIURIC NEPHROLITHIASIS TRIAL BETWEEN UROPHOS-K AND UROCIT-K$228,547
P01 · FY2002 · DK
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT AW$123,390
K23 · FY2002 · RR
STONE FORMING RISK OF CALCIUM CONSUMPTION$321,374
M01 · FY2001 · RR
'UPREGULATED STATES'OF THE VITAMIN D RECEPTOR$321,374
M01 · FY2001 · RR
COMPARATIVE EFFECTS OF CITRACAL, OSCAL, &TUMS ON INTESTINAL CALCIUM$321,374
M01 · FY2001 · RR
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT AW$123,390
K23 · FY2001 · RR
HYPERCALCIURIC NEPHROLITHIASIS TRIAL BETWEEN UROPHOS-K AND UROCIT-K$0
P01 · FY2001 · DK
MENTORED PATIENT-ORIENTED RESEARCH CAREER DEVELOPMENT AW$122,082
K23 · FY2000 · RR
STONE FORMING RISK OF CALCIUM CONSUMPTION$34,838
M01 · FY2000 · RR
COMPARATIVE EFFECTS OF CITRACAL, OSCAL, &TUMS ON INTESTINAL CALCIUM$34,838
M01 · FY2000 · RR
HYPERCALCIURIC NEPHROLITHIASIS TRIAL BETWEEN UROPHOS-K AND UROCIT-K$0
P01 · FY2000 · DK
'UPREGULATED STATES'OF THE VITAMIN D RECEPTOR$0
M01 · FY2000 · RR